Seeking Alpha
 

NxStage Medical, Inc. (NXTM)

- NASDAQ
  • Mar. 10, 2014, 5:49 PM
    | 1 Comment
  • Mar. 8, 2013, 2:33 PM
    Rockwell Medical (RMTI +2.3%) gain today after the company signs a two-year contract with NxStage Medical (NXTM +1.8%) to manufacture dialysate concentrate for the NxStage System One. The device is the only portable hemodialysis system cleared for home use by the FDA.
    | Comment!
  • Nov. 9, 2012, 5:45 PM
    After-hours top gainers, as of 5:15 p.m.: MYRX +23.5%. NXTM +6.5%. BGCP +5.4%. IO +5.3%. MSCC +4.7%.
    After-hours top losers: STSI -10.2%. PEGA -7.5%. ENR -7%. WG -6.7%. EXEL -6%.
    | 1 Comment
  • Mar. 16, 2012, 9:37 AM
    Leerink calls out NxStage Medical (NXTM +1.6%) for a quick gain today after the Medicare Payment Advisory Committee released a report last night that included a positive spin on home hemodialysis reimbursement - viewed as positive for the company.
    | Comment!
  • Feb. 28, 2012, 1:40 PM
    NxStage Medical (NXTM -2.9%) drops on a downgrade to Hold from Feltl & Co. Feltl considers NxStage shares to be richly priced on an enterprise value/sales basis, given the lack of a near-term catalyst to boost adoption of its home hemiodialysis product. It's also worried competition could arrive sooner than expected.
    | Comment!
  • Aug. 3, 2011, 10:27 AM
    NxStage Medical (NXTM +13.9%) pops after reporting record Q2 revenue of $54M (+22% Y/Y) and in-line EPS of -$0.10. The firm raises revenue guidance for FY11 to $210M-$215M, from $205M-$213M.
    | Comment!
Visit Seeking Alpha's
NXTM vs. ETF Alternatives
Company Description
NxStage Medical Inc is a medical device company. The Company develops, manufactures and markets products for the treatment of kidney failure, fluid overload and related blood treatments and procedures.